Oncolytic Virus with Attributes of Vesicular Stomatitis Virus and Measles Virus in Hepatobiliary and Pancreatic Cancers

Oncolytic Virus with Attributes of Vesicular Stomatitis Virus and Measles Virus in Hepatobiliary and Pancreatic Cancers

Recombinant vesicular stomatitis virus (VSV)-fusion and hemagglutinin (FH) was developed by substituting the promiscuous VSV-G glycoprotein (G) gene in the backbone of VSV with genes encoding for the measles virus envelope proteins F and H. Hybrid VSV-FH exhibited a multifaceted mechanism of cancer-...

Full description

Bibliographic Details
Main Authors:	Bolni Marius Nagalo, Camilo Ayala Breton, Yumei Zhou, Mansi Arora, James M. Bogenberger, Oumar Barro, Michael B. Steele, Nathan J. Jenks, Alexander T. Baker, Dan G. Duda, Lewis Rowland Roberts, Stephen J. Russell, Kah Whye Peng, Mitesh J. Borad
Format:	Article
Language:	English
Published:	Elsevier 2020-09-01
Series:	Molecular Therapy: Oncolytics
Subjects:	hepatobiliary cancer measles virus oncolytic viral therapy pancreatic cancer vesicular stomatitis virus hepatocellular carcinoma
Online Access:	http://www.sciencedirect.com/science/article/pii/S2372770520301248

Similar Items

Immunovirotherapy Based on Recombinant Vesicular Stomatitis Virus: Where Are We?
by: Yuguo Zhang, et al.
Published: (2022-06-01)

Oncolytic Vesicular Stomatitis Virus: Optimisation Strategies for Anti-Cancer Therapies
by: Margarita Zinovieva, et al.
Published: (2024-10-01)

Oncolytic Vesicular Stomatitis Virus as a Viro-Immunotherapy: Defeating Cancer with a “Hammer” and “Anvil”
by: Michael Karl Melzer, et al.
Published: (2017-02-01)

Untargeted Lipidomics of Vesicular Stomatitis Virus-Infected Cells and Viral Particles
by: Katherine E. Havranek, et al.
Published: (2021-12-01)

Vesicular Stomatitis Virus: Insights into Pathogenesis, Immune Evasion, and Technological Innovations in Oncolytic and Vaccine Development
by: Mohamed Mustaf Ahmed, et al.
Published: (2024-12-01)

Vesicular Stomatitis Virus–Based Vaccines against Lassa and Ebola Viruses
by: Andrea Marzi, et al.
Published: (2015-02-01)

Vesicular Stomatitis Virus: From Agricultural Pathogen to Vaccine Vector
by: Guodong Liu, et al.
Published: (2021-08-01)

Oncotargeting by Vesicular Stomatitis Virus (VSV): Advances in Cancer Therapy
by: Suman Bishnoi, et al.
Published: (2018-02-01)

Protective Efficacy of Lyophilized Vesicular Stomatitis Virus–Based Vaccines in Animal Model
by: Abd’jeleel Salawudeen, et al.
Published: (2024-05-01)

A single-point mutation in the rubella virus E1 glycoprotein promotes rescue of recombinant vesicular stomatitis virus
by: Pratyush Kumar Das, et al.
Published: (2024-03-01)

Diversity in responses to oncolytic Lassa-vesicular stomatitis virus in patient-derived glioblastoma cells
by: Teddy E. Kim, et al.
Published: (2021-09-01)

Acquired chemoresistance can lead to increased resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus
by: Dakota W. Goad, et al.
Published: (2022-03-01)

RIG‐I‐mediated innate immune signaling in tumors reduces the therapeutic effect of oncolytic vesicular stomatitis virus
by: Pengfei Zhang, et al.
Published: (2023-01-01)

Tamoxifen Protects from Vesicular Stomatitis Virus Infection
by: Lamin B. Cham, et al.
Published: (2019-09-01)

Effect of Recombinant Vesicular Stomatitis Virus–Zaire Ebola Virus Vaccination on Ebola Virus Disease Illness and Death, Democratic Republic of the Congo
by: Neil Rupani, et al.
Published: (2022-06-01)

A Cloned Recombinant Vesicular Stomatitis Virus-Vectored Marburg Vaccine, PHV01, Protects Guinea Pigs from Lethal Marburg Virus Disease
by: Wenjun Zhu, et al.
Published: (2022-06-01)

Efficacy and Immunogenicity of a Recombinant Vesicular Stomatitis Virus-Vectored Marburg Vaccine in Cynomolgus Macaques
by: Vidyleison N. Camargos, et al.
Published: (2024-07-01)

γ-Aminobutyric acid promotes vesicular stomatitis virus infection in mouse macrophages
by: ZHAO Lu, LIU Yang
Published: (2023-06-01)

Recombinant vesicular stomatitis virus vector vaccines for WHO blueprint priority pathogens
by: Anahita Fathi, et al.
Published: (2019-10-01)

The Methyltransferase Region of Vesicular Stomatitis Virus L Polymerase Is a Target Site for Functional Intramolecular Insertion
by: Emmanuel Heilmann, et al.
Published: (2019-10-01)

Collateral Lethal Effects of Complementary Oncolytic Viruses
by: Justin W. Maroun, et al.
Published: (2020-09-01)

Evolution and expansion dynamics of a vector‐borne virus: 2004–2006 vesicular stomatitis outbreak in the western USA
by: Rachel Palinski, et al.
Published: (2021-10-01)

MAP3K7 and CHD1 Are Novel Mediators of Resistance to Oncolytic Vesicular Stomatitis Virus in Prostate Cancer Cells
by: Robert S. Bayne, et al.
Published: (2020-06-01)

Examination of vesicular stomatitis virus-induced morphology changes in individual Vero cells by QMod microscopy
by: Isabel Scholz, et al.
Published: (2020-06-01)

Vesicular Stomatitis Virus Elicits Early Transcriptome Response in <i>Culicoides sonorensis</i> Cells
by: Stacey L. P. Scroggs, et al.
Published: (2023-10-01)

Vesicular Stomatitis Virus Transmission Dynamics Within Its Endemic Range in Chiapas, Mexico
by: Lawrence H. Zhou, et al.
Published: (2024-11-01)

Two Point Mutations in the Glycoprotein of SFTSV Enhance the Propagation Recombinant Vesicular Stomatitis Virus Vectors at Assembly Step
by: Qiang Hu, et al.
Published: (2023-03-01)

Immunogenicity of replication-deficient vesicular stomatitis virus based rabies vaccine in mice
by: Jung-Eun Park, et al.
Published: (2021-12-01)

An HPLC-SEC-based rapid quantification method for vesicular stomatitis virus particles to facilitate process development
by: Adrian Schimek, et al.
Published: (2024-06-01)

Producing Vesicular Stomatitis Virus G (VSVG) Protein and Assessment of its Cytotoxic Activity against Breast Cancer Cells
by: Fereshteh Ghandehari, et al.
Published: (2015-05-01)

Reovirus FAST Protein Enhances Vesicular Stomatitis Virus Oncolytic Virotherapy in Primary and Metastatic Tumor Models
by: Fabrice Le Boeuf, et al.
Published: (2017-09-01)

Full Genomic Sequencing of Vesicular Stomatitis Virus Isolates from the 2004–2006 US Outbreaks Reveals Associations of Viral Genetics to Environmental Variables
by: Rachel Palinski, et al.
Published: (2020-06-01)

A Surrogate Animal Model for Screening of Ebola and Marburg Glycoprotein-Targeting Drugs Using Pseudotyped Vesicular Stomatitis Viruses
by: Takeshi Saito, et al.
Published: (2020-08-01)

Vesicular Stomatitis Virus Transmission: A Comparison of Incriminated Vectors
by: Paula Rozo-Lopez, et al.
Published: (2018-12-01)

Characterization of a Vesicular Stomatitis Virus-Vectored Recombinant Virus Bearing Spike Protein of SARS-CoV-2 Delta Variant
by: Wenwen He, et al.
Published: (2023-02-01)

Development of a vesicular stomatitis virus pseudotyped with herpes B virus glycoproteins and its application in a neutralizing antibody detection assay
by: Hitomi Kinoshita, et al.
Published: (2024-07-01)

Comparison of Endemic and Epidemic Vesicular Stomatitis Virus Lineages in <i>Culicoides sonorensis</i> Midges
by: Paula Rozo-Lopez, et al.
Published: (2022-06-01)

A Natural Botanical Product, Resveratrol, Effectively Suppresses Vesicular Stomatitis Virus Infection In Vitro
by: Shih-Chao Lin, et al.
Published: (2021-06-01)

The Oncolytic Virus VSV-GP Is Effective against Malignant Melanoma
by: Janine Kimpel, et al.
Published: (2018-03-01)

Fibrinogen Gamma Chain Promotes Aggregation of Vesicular Stomatitis Virus in Saliva
by: Valesca Anschau, et al.
Published: (2020-03-01)